Get 20% off on Global Market Reports until March 31st! Use code FY25SAVE at checkout.

What fueled the previous growth in the gestational diabetes market?

The market size for gestational diabetes has seen robust growth in the recent past. The market is projected to escalate from $8.37 billion in 2024 to $9.14 billion in 2025, marking a compound annual growth rate (CAGR) of 9.3%. The profound growth experienced during the past years can be traced back to factors such as the heightened risk of diabetes, improvements in the precision of blood glucose level measurements, an upsurge in the number of insurance providers, a rise in the population of patients with diabetes, and an overall increase in the diabetes population.

What will be the gestational diabetes market size in the future?

Expectations are high for significant expansion in the gestational diabetes market in the coming years. Projections put the market at a value of $12.90 billion by 2029, calculated with a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this predicted growth within the forecast period include the rising obesity rates, the growing embracement of cloud-based project solutions, and the increased use of related equipment and applications. Further reasons include the rising prevalence of diabetes linked to unhealthy lifestyles, higher public health awareness, and escalating diabetes incidence rates. Notable trends anticipated during the forecast period encompass digital tools for diabetes management, autonomous control systems, diabetes management technology, enzymatic technology, and pioneering medical innovations.

Get your gestational diabetes market report here!

https://www.thebusinessresearchcompany.com/report/gestational-diabetes-global-market-report

What main drivers are fueling expansion in the gestational diabetes market?

The surge in the population suffering from obesity is predicted to stimulate the expansion of the gestational diabetes market in the future. People who have a body mass index (BMI) of 30 or above, indicating an unhealthy amount of body fat, are deemed obese. The rise in the obese population is due to several factors, including a sedentary lifestyle, an uptick in the consumption of high-calorie, processed foods, genetic factors, and a lack of access to nutritious food and physical activity options. Treatment for gestational diabetes is incredibly important for obese individuals as they are at a higher risk for insulin resistance and excessive weight gain during pregnancy, which if unmanaged, could lead to complications for both the mother and the baby. In the example of March 2024, the World Health Organization, an intergovernmental organization based in Switzerland, stated that approximately one in eight people worldwide were obese in 2022, and there were 2.5 billion adults aged 18 and above who were considered overweight, including 890 million individuals suffering from obesity. Among adults, 43% were overweight, and 16% were obese. Furthermore, there were 37 million children under 5 years of age who were overweight, and over 390 million children and adolescents aged 5-19 years were overweight, with 160 million of them being obese. Thus, the rise in obesity is a key driver for the gestational diabetes market’s growth.

What key areas define the segmentation of the global gestational diabetes market?

The gestational diabetes market covered in this report is segmented –

1) By Types: Type A1, Type A2, Other Types

2) By Treatment: Monitoring, Drug Treatment, Non-pharmacological treatment

3) By Administration: Oral, Intravenous, Other Administrations

4) By End User: Hospitals, Clinics, Home Care Settings, Diagnostic Centers

Subsegments:

1) By Type A1: Diet-Controlled Gestational Diabetes, Exercise-Controlled Gestational Diabetes

2) By Type A2: Insulin-Controlled Gestational Diabetes, Oral Medication-Controlled Gestational Diabetes

3) By Other Types: Pre-Gestational Diabetes, Gestational Diabetes With Complications

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20818&type=smp

Who are the dominant players expanding their reach in the gestational diabetes market?

Major companies operating in the gestational diabetes market are Sanofi S.A., AstraZeneca plc, Abbott Laboratories, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, Boehringer Ingelheim GmbH, Dexcom Inc, Biocon Limited, LifeScan Inc, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Nipro Diagnostics, Inc., Sernova Corp., ZyVersa Therapeutics, Inc., Peptron Inc., Roche Diabetes Care, DiabetOmics Inc, Merck & Co. Inc., Medtronic plc

What are the key trends shaping the future of the gestational diabetes market?

Major companies operating in the gestational diabetes market are focusing on developing technologically advanced products, such as diagnostic kits for gestational diabetes, to provide quick, accurate, and convenient methods for early detection. A diagnostic kit for gestational diabetes is a medical tool used to measure blood glucose levels and identify abnormal glucose tolerance in pregnant women, aiding in the early detection and management of the condition. For instance, in August 2024, DirectSens GmbH, an Austria-based biotechnology company, launched the XpressGT RUO kit, a diagnostic kit designed to diagnose gestational diabetes, endometriosis, insulin resistance, and liver disease. It accurately measures 2-hydroxybutyrate (2-HB) levels found in venous blood, naturally produced by the liver during its normal functions. Elevated 2-HB levels are associated with increased reductive stress, linked to various endocrine and obesity-related disorders, including insulin resistance. The kit is compatible with any available clinical analyzer and delivers results in just 8 minutes, offering a fast and efficient diagnostic solution.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20818

Which regions are emerging as leaders in the gestational diabetes market?

North America was the largest region in the gestational diabetes market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gestational diabetes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Diabetes Care Devices Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/diabetes-care-devices-market

Global Diabetes Therapies Opportunities And Strategies Global Market Report 2025

https://thebusinessresearchcompany.com/report/diabetes-therapies-market

Global Digital Diabetes Management Global Global Market Report 2025

https://thebusinessresearchcompany.com/report/digital-diabetes-management-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: